Form 4: Teladoc CEO Divita Sells Shares for Tax Withholding

Teladoc Health CEO Charles Divita III sold shares to cover tax obligations related to vesting stock units, impacting his beneficial ownership.

Summary

• Charles Divita III, CEO of Teladoc Health, reported transactions on June 1st and June 2nd, 2026.
• On June 1st, 1,966 performance stock units converted into common stock, and 42,276 restricted stock units converted into common stock.
• These conversions resulted in a total of 44,242 shares acquired by Divita.
• On June 2nd, 19,132 shares were sold at $7.627 per share to cover tax withholding obligations associated with the vesting of these units.
• Following these transactions, Divita's beneficial ownership of Teladoc Health common stock stands at 389,894 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine tax-related transaction for equity compensation, not indicative of a change in the CEO's outlook on the company's performance.

Negatives

• The sale of shares by the CEO to cover tax obligations, while standard, reduces his direct holdings.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales by C-suite executives, are closely watched by the market. While this transaction is for tax withholding, which is a common and often unavoidable event, any significant reduction in insider holdings can be interpreted by investors as a signal, regardless of the underlying reason.

Stakeholder Impact

• Shareholders: The sale reduces the number of shares held directly by the CEO, which could be perceived negatively if not understood as a tax-related event. However, the underlying equity awards were previously granted and vested.
• Employees: The transaction is related to executive compensation and does not directly impact other employees.
• Creditors: No direct impact on creditors.
• Suppliers/Customers: No direct impact.

Key Dates

Keywords

Teladoc Health, TDOC, Form 4, Insider Trading, Stock Sale, CEO, Charles Divita III, Performance Stock Units, Restricted Stock Units, Tax Withholding